HCT Stock Overview
Holista CollTech Limited operates as a research-driven biotech company in Australia, Malaysia, and the United States.
Snowflake Score | |
---|---|
Valuation | 2/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 0/6 |
Dividends | 0/6 |
Holista Colltech Limited Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | AU$0.013 |
52 Week High | AU$0.015 |
52 Week Low | AU$0.004 |
Beta | -0.35 |
11 Month Change | 160.00% |
3 Month Change | n/a |
1 Year Change | 18.18% |
33 Year Change | -79.03% |
5 Year Change | -78.33% |
Change since IPO | -90.00% |
Recent News & Updates
Recent updates
Shareholder Returns
HCT | AU Personal Products | AU Market | |
---|---|---|---|
7D | 30.0% | -3.6% | -2.3% |
1Y | 18.2% | 10.6% | 5.2% |
Return vs Industry: HCT exceeded the Australian Personal Products industry which returned 10.6% over the past year.
Return vs Market: HCT exceeded the Australian Market which returned 5.2% over the past year.
Price Volatility
HCT volatility | |
---|---|
HCT Average Weekly Movement | n/a |
Personal Products Industry Average Movement | 5.9% |
Market Average Movement | 8.0% |
10% most volatile stocks in AU Market | 16.3% |
10% least volatile stocks in AU Market | 3.3% |
Stable Share Price: HCT's share price has been volatile over the past 3 months.
Volatility Over Time: Insufficient data to determine HCT's volatility change over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
n/a | n/a | n/a | www.holistaco.com |
Holista CollTech Limited operates as a research-driven biotech company in Australia, Malaysia, and the United States. The company operates through Supplements, Ovine Collagen, Food Ingredients, and Infection Control Solutions segments. It manufactures and wholesales dietary supplements; cosmetic grade collagen; infection control solutions; and healthy food ingredients, including low-glycemic index (GI) bread, noodles/pasta, and flatbreads, as well as low-calorie/low-GI sugar substitutes.
Holista Colltech Limited Fundamentals Summary
HCT fundamental statistics | |
---|---|
Market cap | AU$3.62m |
Earnings (TTM) | -AU$4.81m |
Revenue (TTM) | AU$5.95m |
0.6x
P/S Ratio-0.8x
P/E RatioIs HCT overvalued?
See Fair Value and valuation analysisEarnings & Revenue
HCT income statement (TTM) | |
---|---|
Revenue | AU$5.95m |
Cost of Revenue | AU$3.32m |
Gross Profit | AU$2.62m |
Other Expenses | AU$7.43m |
Earnings | -AU$4.81m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
Earnings per share (EPS) | -0.017 |
Gross Margin | 44.10% |
Net Profit Margin | -80.81% |
Debt/Equity Ratio | -39.5% |
How did HCT perform over the long term?
See historical performance and comparison